The novel treatment of the medication represents a exciting development in the management of the condition. Unlike existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide965947.blogsvila.com/42350379/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment